Market Place
Sourcing Support
Selecta Biosciences Announces Merger with Cartesian Therapeutics
13 Nov 2023 //
GLOBENEWSWIRE
Selecta fuses with Cartesian in reverse merger
13 Nov 2023 //
FIERCE BIOTECH
Selecta Announces Transition of Clinical Operations of ImmTOR for SEL-212
31 Oct 2023 //
GLOBENEWSWIRE
Selecta narrows focus to gout drug, freezing rest of pipeline
17 Aug 2023 //
FIERCE BIOTECH
Selecta Biosciences Reports Second Quarter 2023 Financial Results
17 Aug 2023 //
GLOBENEWSWIRE
Selecta Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212
31 May 2023 //
GLOBENEWSWIRE
Selecta Biosciences Reports 1Q 2023 FYR and Provides Business Update
04 May 2023 //
GLOBENEWSWIRE
Selecta lets go 25% of workforce, pauses PhI/II gene therapy trial
04 May 2023 //
ENDPTS
Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon
22 Mar 2023 //
FIERCE BIOTECH
Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout Meets Endpoint
21 Mar 2023 //
GLOBENEWSWIRE
Selecta Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
02 Mar 2023 //
GLOBENEWSWIRE
Selecta Biosciences to Discuss Fourth Quarter & Full-Year 2022 Financial Results
23 Feb 2023 //
GLOBENEWSWIRE
Selecta to Participate at the SVB Securities Global Biopharma Conference
07 Feb 2023 //
GLOBENEWSWIRE
Selecta Biosciences Provides Business Update and Outlook for 2023
09 Jan 2023 //
GLOBENEWSWIRE
Astellas` intergalactic quest finds 2 pacts with Twist, Selecta
09 Jan 2023 //
FIERCE BIOTECH
Selecta Announces Next Generation IgA Protease Clinical Candidate Selection
14 Dec 2022 //
GLOBENEWSWIRE
Selecta Biosciences Appoints Blaine Davis as CFO
28 Nov 2022 //
BIOSPACE
Selecta Announces Appointment of Blaine Davis as Chief Financial Officer
28 Nov 2022 //
GLOBENEWSWIRE
Selecta Biosciences to Participate at the Guggenheim Healthcare Talks
07 Nov 2022 //
GLOBENEWSWIRE
Selecta Biosciences Reports Third Quarter 2022 Financial Results
03 Nov 2022 //
GLOBENEWSWIRE
Selecta to Host Conference Call to Discuss Third Quarter 2022 Financial Results
27 Oct 2022 //
GLOBENEWSWIRE
Selecta Biosciences Announces Three Presentations at the Upcoming 29th (ESGCT)
11 Oct 2022 //
GLOBENEWSWIRE
Selecta Biosciences Board Member, Timothy Springer, Ph.D., Wins Lasker Award
29 Sep 2022 //
GLOBENEWSWIRE
Selecta Biosciences to Participate at the H.C. Wainwright 24th AnnualGIC
06 Sep 2022 //
GLOBENEWSWIRE
Selecta Biosciences Reports Second Quarter 2022 Financial Results
04 Aug 2022 //
GLOBENEWSWIRE
Selecta Biosciences to Participate in Upcoming Investor Conferences
01 Aug 2022 //
GLOBENEWSWIRE
Selecta Bio to Host Conference Call on Second Quarter 2022 Financial Results
28 Jul 2022 //
GLOBENEWSWIRE
Selecta Biosciences to Participate at the Guggenheim Conference
06 Jul 2022 //
GLOBENEWSWIRE
Selecta Biosciences Announces Partnership Advancements and Trial Updates
13 Jun 2022 //
GLOBENEWSWIRE
Selecta Biosciences to Participate at the H.C. Wainwright Conference
17 May 2022 //
GLOBENEWSWIRE
Selecta Biosciences Reports First Quarter 2022 Financial Results
05 May 2022 //
GLOBENEWSWIRE
Selecta Biosciences Announces Six Presentations at the Upcoming 25th ASGCT
02 May 2022 //
GLOBENEWSWIRE
Selecta Biosciences to Discuss First Quarter 2022 Financial Results
28 Apr 2022 //
GLOBENEWSWIRE
Selecta Biosciences Announces $38.7 Million Underwritten Offering
06 Apr 2022 //
GLOBENEWSWIRE
Selecta clinical hold on gene therapy lifted
11 Mar 2022 //
FIERCEBIOTECH
Selecta Bio Reports Q4 and FY 2021 Financial Results
10 Mar 2022 //
GLOBENEWSWIRE
Selecta Biosciences to Participate at the SVB Leerink 11th Annual Conference
09 Feb 2022 //
GLOBENEWSWIRE
Selecta, Ginkgo Bioworks Collaborate to Develop Next-Gen Gene Therapy Capsids
10 Jan 2022 //
PRNEWSWIRE
Selecta Biosciences to Participate at the LifeSci Partners 11th Annual
29 Dec 2021 //
GLOBENEWSWIRE
Sobi and Selecta Biosciences complete enrolment for gout therapy trial
02 Dec 2021 //
CLINICALTRIALSARENA
Sobi and Selecta announce completion of enrolment in Phase 3 study of SEL-212
01 Dec 2021 //
BIOSPACE
FDA places clinical hold on Selecta Biosciences’ trial of MMA gene therapy
26 Nov 2021 //
CLINICALTRIALSARENA
Selecta Biosciences Announces Top Line Data from the Phase I SEL-399 AAV
08 Nov 2021 //
GLOBENEWSWIRE
AI upstart grabs $40M launch round; Sanofi backs gene therapy player; & more
08 Nov 2021 //
ENDPTS
Selecta Biosciences &Ginkgo Bioworks Announce Partnership to Advance Treatments
26 Oct 2021 //
GLOBENEWSWIRE
Takeda inks another biobucks pact: $900M for Immusoft`s B cells
14 Oct 2021 //
FIERCEBIOTECH
Selecta Biosciences to Present New Data for the ImmTOR™ platform
13 Oct 2021 //
GLOBENEWSWIRE
Poseida, Takeda ink $3.6B pact for 8 non-viral gene therapies
13 Oct 2021 //
FIERCEBIOTECH
Companies Enter Licensing Agreements to Expand Gene Therapy Programs
12 Oct 2021 //
BIOSPACE
Takeda, Moderna and more—Fierce Pharma Asia
08 Oct 2021 //
FIERCEPHARMA
Voyager pens Pfizer gene therapy pact worth $630M
07 Oct 2021 //
FIERCEBIOTECH
Takeda taps Selecta for $1.1B gene therapy research pact
05 Oct 2021 //
FIERCEBIOTECH
Selecta Biosciences Announces Strategic Licensing Agreement with Takeda
04 Oct 2021 //
GLOBENEWSWIRE
Selecta Biosciences Announces Appointment of Kevin Tan as CFO
20 Sep 2021 //
GLOBENEWSWIRE
Selecta & Cyrus Biotech. Collaborate for Novel Engineered Therapeutic Proteins
08 Sep 2021 //
GLOBENEWSWIRE
Selecta Biosciences to Participate in Upcoming Investor Conferences
02 Aug 2021 //
GLOBENEWSWIRE
Selecta special Publication of Data Evaluating with AAV vectors the treatment
26 Jul 2021 //
GLOBENEWSWIRE
Selecta Biosciences to Participate at the William Blair Biotech Conference 2021
08 Jul 2021 //
GLOBENEWSWIRE
Selecta Biosciences Appoints Nishan de Silva to Board of Directors
24 Jun 2021 //
GLOBENEWSWIRE
Selecta to Participate at the Raymond James Human Health Innovation Conference
16 Jun 2021 //
GLOBENEWSWIRE
